DAVID NUFFER, District Judge.
Defendants Rite Aid Corporation, Thrifty Payless Holdings, Inc., Rite Aid Lease Management Company, and Thrifty Payless, Inc. (collectively "Rite Aid") filed a Motion for Partial Summary Judgment ("Motion") dismissing Plaintiff's claims relating to the second incident in the Amended Complaint
Plaintiff Susie Whiting ("Mrs. Whiting") alleges that Linda Smith ("Smith"), a pharmacist employed by Rite Aid, breached her duty to warn and give good advice about whether Ms. Whiting's husband could safely take Sudafed.
Mrs. Whiting alleges that based upon Smith's advice that it was safe, Mr. Whiting took one Sudafed pill. Subsequently, the Sudafed allegedly exacerbated symptoms of Mr. Whiting's "prostate trouble" and he suffered from difficulty urinating, bladder distension, and burst blood vessels in his bladder.
After Mr. Whiting's death, Mrs. Whiting sued Rite Aid alleging medical malpractice, res ipsa loquitur, and lack of informed consent arising from Smith's negligence and bad advice.
Rite Aid argues that the pharmacist standard of care adopted by the Utah Supreme Court in Schaerrer v. Stewart's Plaza Pharmacy, Inc.
Rite Aid also argues that even if the duty of care extends to nonprescription drugs like Sudafed, the learned intermediary doctrine shields Rite Aid from liability because Smith was not Mr. Whiting's physician and did not have access to him or his medical history.
"The court shall grant summary judgment if the movant shows that there is no genuine dispute as to material fact and the movant is entitled to judgment as a matter of law."
As discussed above, the parties dispute material facts, particularly about whether Mrs. Whiting phoned Smith about whether it was safe for Mr. Whiting to take Sudafed. This dispute would normally preclude summary judgment. But Rite Aid argues that even under Mrs. Whiting's alleged facts, Rite Aid cannot be liable as a matter of law because a pharmacist has no duty regarding nonprescription drugs. Whether a duty exists is a question of law.
The Utah Supreme Court has not yet expressly stated whether a pharmacist may be liable for dispensing advice about nonprescription drugs. This court should analyze and evaluate Utah law to predict what the Utah Supreme Court would do when faced with this issue.
The Utah Supreme Court has previously held that although "pharmacists are exempt from strict products liability in Utah, [they] may still be liable for claims of professional malpractice or negligence."
Utah law recognizes that pharmacists and pharmacies may give advice and recommendations to customers about nonprescription drugs. For example, the Utah Code defines "patient counseling" as "the written and oral communication by the pharmacist or pharmacy intern of information, to the patient or caregiver, in order to ensure proper use of drugs ..."
Pharmacists in Utah clearly have duties regarding nonprescription drugs. If a pharmacist answers a customer's question and offers advice about nonprescription drugs, the pharmacist must advise and act in a non-negligent manner consistent with a reasonably prudent pharmacist's response to a customer's question about the safety of a nonprescription drug. And this question is inextricably tied to facts and needs expert testimony to establish the standard of care of a reasonably prudent pharmacist in this situation.
Imposition of a duty regarding nonprescription drugs is consistent with Utah law and public policy. "A duty, in negligence cases, may be defined as an obligation, to which the law will give recognition and effect, to conform to a particular standard of conduct toward another."
Policy judgments applied to the relationship between pharmacist and customer mandate that pharmacists have a duty to their customers. Pharmacists can avoid liability for failure to warn in the prescription drug context when they are viewed only as service providers — namely because the law restricts what they can "sell." A pharmacist can only "sell" what the customer's doctor has prescribed to the customer. In the prescription drug setting, pharmacists are not sellers because they do not market and sell prescription drugs to customers, and customers do not choose which prescription drugs they will purchase based upon the recommendations or
But nonprescription drug sales are not determined or limited by a physician's prescription. A customer may "shop" for a nonprescription drug, and a pharmacist may market and sell nonprescription drugs to customers without any input or advice from a medical doctor. If pharmacists offer advice and recommendations to customers about nonprescription drugs, pharmacists are less like service providers and more like sellers of any other product. They may market and sell nonprescription drugs and may offer advice about those nonprescription drugs, including whether they will interact with other drugs — both prescription and nonprescription alike. This advice has an independently powerful effect on the purchaser.
In a modern day pharmacy, where pharmacists serve as both "sellers" and service providers, if a pharmacy offers advice and recommendations about nonprescription drugs, and that advice turns out to be contrary to what a reasonably prudent pharmacist would give in a similar situation, the pharmacy cannot reap the benefits of offering advice but then hide behind the learned intermediary doctrine to avoid the consequences if their advice is incorrect. This is especially so when pharmacies often hold themselves out to the public and the pharmacy's customers as experts on drugs — both prescription and nonprescription alike.
A pharmacist has a duty to act in a manner consistent with a reasonably prudent pharmacist. Expert testimony is necessary to establish whether Smith breached this duty based upon the factual circumstances alleged.
The learned intermediary doctrine does not apply to shield a pharmacy or pharmacist from liability for failure to warn in the nonprescription drug context. In Schaerrer v. Stewart's Plaza Pharmacy, Inc.,
Adoption of the learned intermediary doctrine with respect to pharmacists was based in part on the "unique set of relationships" among pharmacists, physicians, customers, and drug manufacturers in the prescription drug context. This unique relationship exists because "[b]oth manufacturers and pharmacists are limited in their ability to distribute FDA-regulated drugs because neither has direct access to the patient."
Over the counter drugs, like Sudafed, are FDA-regulated drugs.
The Utah Supreme Court concluded:
In Utah, the learned intermediary doctrine only shields pharmacists from failure to warn about prescription drugs. It has no application in the factually different context of nonprescription drugs. Because the issue in this case involves Smith's alleged advice regarding the safety of Sudafed, a nonprescription drug, Rite Aid is not protected by the learned intermediary doctrine.
IT IS HEREBY ORDERED that Rite Aid's Motion for Partial Summary Judgment is DENIED.